The European Union has tabled an amendment to its Cosmetics Regulation that would ban 15 substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR) and revise Annexes III, IV and V in a single legislative step.

For formulators and regulatory teams across the bloc, the proposal signals a fresh cycle of compliance work: reformulation for any product line that still contains the affected ingredients, label and safety report updates, and a review of supplier documentation against the revised annexes. The draft, reported by CIRS Group, consolidates the CMR bans with technical amendments to the annexes governing restricted substances, colorants and preservatives.

What does the amendment actually change?

Two things move at once. First, the 15 CMR-designated substances would be prohibited outright in cosmetic products placed on the EU market. CMR classification under the CLP Regulation triggers this pathway under Article 15 of the Cosmetics Regulation (EC) No 1223/2009, which generally bars CMR 1A and 1B substances unless a specific exemption applies.

Second, Annexes III, IV and V — the lists of restricted substances, colourants and preservatives respectively — would be revised. That means concentration limits, permitted uses and entry conditions inside those annexes are on the table, not just the headline bans. Compliance teams will need to check each reformulated product against the new annex text rather than assume a simple delete-list.

What does this change for product development?

The practical question for any brand selling into the EU: does the current portfolio touch any of the 15 substances? If the answer is yes, the work is threefold.

• Reformulation or discontinuation of affected SKUs, including supplier-side raw material blends where the CMR substance appears as a component rather than a declared ingredient.
• Safety assessment updates — the Product Information File and the responsible person's sign-off must reflect the new legal status once adopted.
• Procurement review, since raw material specifications and certificates of analysis may need renegotiation with suppliers whose portfolios include the listed substances.

For contract manufacturers, the amendment adds a client-notification burden: brands will expect their fillers to flag which formulations fall within scope as soon as the substance list is confirmed.

Why CMR bans arrive in batches

The mechanism is familiar to EU watchers. When the European Chemicals Agency's Committee for Risk Assessment classifies a substance as CMR 1A or 1B under CLP, the European Commission typically follows with a Cosmetics Regulation amendment to align the annexes. Grouping 15 substances into one proposal, alongside annex revisions, is the established efficiency move — and it signals that more classifications are feeding through the pipeline.

Preservative and colorant annex revisions deserve particular attention. Annex V (preservatives) has been under continuous pressure as substances lose approval, narrowing the toolbox for formulators who must still meet microbiological challenge requirements. Any deletion or restriction there compounds an already tight supply of accepted preservative systems.

What to watch next

The proposal now passes through the standard legislative sequence: scrutiny by the European Parliament and Council, then adoption and publication in the Official Journal, with the amendment typically applying from a date set in the text — often with a sell-through window for stock already on shelves. Formulators should track the named substance list as it moves toward adoption, and diaries the date of application the moment it is fixed. Until then, nothing is banned yet — but early reformulation scoping will separate the prepared from the penalised.